Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 177 of the 181 references it cites were found in a registry or an index.
Abstract
This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacological and psychosocial interventions for ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulant medications are effective in reducing ADHD symptoms in the short-term and are recognized as the first-line treatment option for school-aged children, adolescents, and adults (10–12).”
From ADHD Medication and Substance-Related Problems (2017) · cites this paper as [12]
In the citing paper
“Furthermore, current guidelines are inconsistent in their treatment recommendations.9, 10, 11, 12, 13, 14”
In the citing paper
“For ADHD, empirical support exists for behavioral training for parents of children with ADHD [53] and cognitive behavioral therapy for affected adults [54].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [53]
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,639
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Improving Primary Care for Patients With Chronic Illness
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.14.1775 · Cited by 2,961
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
(1998) · Cited by 2,026
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
BARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507
Research works printed but not linked: 5
- Klein, 1998, Resolved: mania is mistaken for ADHD in prepubertal children, negative, J Am Acad Child Adolesc Psychiatry, 37, 1093
- Swanson, 2000, Initiating Concerta OROS methylphenidate HCI qd in children with attention-deficit hyperactivity disorder, J Clin Res, 3, 59
- Wigal, 2003, Selection of the optimal dose ratio for a controlled-delivery formulation of methylphenidate, J Appl Res, 3, 46
- Wilens T, Gao H, Thomason C, Gelowitz D, Kratochvil C, Newcorn J (2004), Longer term treatment with atomoxetine in adolescents with ADHD. Scientific Proceedings of the American Psychiatric Association No. 578, New York, May
- Wolraich, 2000, Evaluation of efficacy and safety or OROS methylphenidate HCI MPH extended release tablets, methylphenidate tid, and placebo in children with ADHD, Pediatr Res, 47, 36A
Cited by
Items 301–400 of 1,006
COMT as a Drug Target for Cognitive Functions and Dysfunctions
Scheggia, D., Sannino, S., Scattoni, M. L., & Papaleo, F. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672481 · Cited by 57
Sahin, S., Yuce, M., Alacam, H., Karabekiroglu, K., Say, G. N., & Salıs, O. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.940054 · Cited by 52
Stimulant Medication Treatment of Target Behaviors in Children with Autism: A Population-Based Study
Nickels, K. C., Katusic, S. K., Colligan, R. C., Weaver, A. L., Voigt, R. G., & Barbaresi, W. J. (2008) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31815f24f7 · Cited by 51
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
Behavioral Assessment of Core ADHD Symptoms Using the QbTest
Reh, V., Schmidt, M., Lam, L., Schimmelmann, B. G., Hebebrand, J., Rief, W., & Christiansen, H. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712472981 · Cited by 51
A Novel Group Therapy for Children With ADHD and Severe Mood Dysregulation
Waxmonsky, J. G., Wymbs, F. A., Pariseau, M. E., Belin, P. J., Waschbusch, D. A., Babocsai, L., Fabiano, G. A., Akinnusi, O. O., Haak, J. L., & Pelham, W. E. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711433423 · Cited by 51
Attention-deficit/hyperactivity disorder (ADHD)
Dalsgaard, S. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0360-z · Cited by 66
Cortese, S., Konofal, É., Bernardina, B. D., Mouren, M., & Lecendreux, M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.036 · Cited by 57
Schneider, J. P., Matthews, M. L., & Jamison, R. N. (2010) · CNS Drugs · doi:10.2165/11584260-000000000-00000 · Cited by 57
How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition
Hawk, L. W., Fosco, W. D., Colder, C. R., Waxmonsky, J. G., Pelham, W. E., & Rosch, K. S. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12917 · Cited by 51
Adult-Onset ADHD: A Critical Analysis and Alternative Explanations
Taylor, L. E., Kaplan-Kahn, E. A., Lighthall, R. A., & Antshel, K. M. (2022) · Child Psychiatry & Human Development · doi:10.1007/s10578-021-01159-w · Cited by 50
Meppelink, R., de Bruin, E. I., & Bögels, S. M. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0978-3 · Cited by 50
Tamm, L., Denton, C. A., Epstein, J. N., Schatschneider, C., Taylor, H., Arnold, L. E., Bukstein, O., Anixt, J., Koshy, A., Newman, N. C., et al. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000170 · Cited by 60
Comorbid ADHD: Implications for the Treatment of Anxiety Disorders in Children and Adolescents
Halldorsdottir, T., & Ollendick, T. H. (2013) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2013.08.003 · Cited by 60
An international perspective on pediatric psychopharmacology
Vitiello, B. (2008) · International Review of Psychiatry · doi:10.1080/09540260801887710 · Cited by 51
Dickson, R. A., Maki, E., Gibbins, C., Gutkin, S. W., Turgay, A., & Weiss, M. D. (2011) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-5-14 · Cited by 50
Kratz, O., Studer, P., Baack, J., Malcherek, S., Erbe, K., Moll, G. H., & Heinrich, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.008 · Cited by 58
Newcorn, J. H., Nagy, P., Childress, A. C., Frick, G., Yan, B., & Pliszka, S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0468-2 · Cited by 50
Self-citationKrakowski, A. D., Cost, K. T., Anagnostou, E., Lai, M.-C., Crosbie, J., Schachar, R., Georgiades, S., Duku, E., & Szatmari, P. (2020) · Molecular Autism · doi:10.1186/s13229-020-00338-1 · Cited by 50
Assessment of stimulant use and cardiovascular event risks among older adults
Tadrous, M., Shakeri, A., Chu, C., Watt, J., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30795 · Cited by 49
DeMaso, D. R., Martini, D. R., & Cahen, L. A. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b13e3181908bf4 · Cited by 51
Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder
Vaughan, B., Fegert, J., & Kratochvil, C. J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902762873 · Cited by 49
Wigal, S. B., Childress, A. C., Belden, H. W., & Berry, S. A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0073 · Cited by 49
Aguiar, A. P., Kieling, R. R., Costa, A. C., Chardosim, N. M. D. O., Dorneles, B. V., de Almeida, M. R., Mazzuca, A. C. M., Kieling, C., & Rohde, L. A. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712453171 · Cited by 71
Fulton, B. D., Scheffler, R. M., & Hinshaw, S. P. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400145 · Cited by 49
Yang, R., Mao, S., Zhang, S., Li, R., & Zhao, Z. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-133 · Cited by 49
Morales‐Hidalgo, P., Hernández‐Martínez, C., Vera, M., Voltas, N., & Canals, J. (2016) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2016.07.003 · Cited by 62
Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy
Douniol, M., Jacquette, A., Guilé, J.-M., Tanguy, M., Angeard, N., Héron, D., Plaza, M., & Cohen, D. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0037-4 · Cited by 54
Jurek, L., Duchier, A., Gauld, C., Henault, L., Giroudon, C., Fourneret, P., Cortese, S., & Nourredine, M. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.02.019 · Cited by 74
Traditional Chinese Medicine in the Treatment of ADHD
Ni, X., Zhang‐James, Y., Han, X., Lei, S., Sun, J., & Zhou, R. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.011 · Cited by 56
The Shifting Subtypes of ADHD: Classification Depends on How Symptom Reports are Combined
Rowland, A. S., SKIPPER, B. J., Rabiner, D. L., Umbach, D. M., Stallone, L., Campbell, R. A., Hough, R. L., Naftel, A. J., & Sandler, D. P. (2008) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-007-9203-7 · Cited by 63
A Review of the Use of Clonidine as a Sleep Aid in the Child and Adolescent Population
Nguyen, M. L., Tharani, S., Rahmani, M., & Shapiro, M. A. (2013) · Clinical Pediatrics · doi:10.1177/0009922813502123 · Cited by 52
Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD
Sasser, T. R., Schoenfelder, E. N., & Stein, M. A. (2016) · CNS Drugs · doi:10.1007/s40263-016-0400-1 · Cited by 57
Coles, E. K., Pelham, W. E., Fabiano, G. A., Gnagy, E. M., Burrows-MacLean, L. D., Wymbs, B. T., Chacko, A., Walker, K. S., Wymbs, F. A., Mazzant, J. R., et al. (2019) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2019.1630835 · Cited by 56
Mental Health Implications of Traumatic Brain Injury (TBI) in Children and Youth.
Schachar, R. J., Park, L. S., & Dennis, M. (2015) · Europe PMC (PubMed Central) · Cited by 73
Devena, S. E., & Watkins, M. W. (2012) · Journal of Applied School Psychology · doi:10.1080/15377903.2012.669743 · Cited by 47
Designing for Care Ecosystems: a Literature Review of Technologies for Children with ADHD
Stefanidi, E., Schöning, J., Feger, S. S., Marshall, P., Rogers, Y., & Niess, J. (2022) · ACM International Conference on Interaction Design and Children (IDC) · doi:10.1145/3501712.3529746 · Cited by 52
Gobbo, M. A., & Louzã, M. R. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.006 · Cited by 46
Treatment Patterns, Adherence, and Persistence in ADHD: A Canadian Perspective
Lachaîne, J., Beauchemin, C., Sasané, R., & Hodgkins, P. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.05.2557 · Cited by 51
Group cognitive behavioral therapy for children and adolescents with ADHD
Coelho, L. F., Barbosa, D. L. F., Rizzutti, S., Bueno, O. F. A., & Miranda, M. C. (2017) · Psicologia Reflexão e Crítica · doi:10.1186/s41155-017-0063-y · Cited by 62
Cortese, S., Faraone, S. V., Konofal, É., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ae09c9 · Cited by 117
Once-daily treatment of ADHD with guanfacine: patient implications
Strange, B. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1711 · Cited by 45
Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder
Vaughan, B., & Kratochvil, C. J. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.005 · Cited by 46
Exercise Intervention in Treatment of Neuropsychological Diseases: A Review
Chen, Z., Lan, W., Yang, G., Li, Y., Xiang, J., Chen, L., Zhou, Y. N., & Li, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.569206 · Cited by 59
Nasser, A. F., Liranso, T., Adewole, T., Fry, N., Hull, J. T., Busse, G. D., Chowdhry, F. A., Cutler, A. J., Jones, N. J., Findling, R. L., et al. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001404 · Cited by 49
Psychosocial Interventions in Attention-Deficit/Hyperactivity Disorder
Antshel, K. M. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.08.002 · Cited by 72
Pottegård, A., Bjerregaard, B. K., Glintborg, D., Kortegaard, L. S., Hallas, J., & Moreno, S. I. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1344-0 · Cited by 51
Cortese, S., Adamo, N., Mohr-Jensen, C., Hayes, A. J., Bhatti, S., Carucci, S., Del Giovane, C., Atkinson, L. Z., Banaschewski, T., Simonoff, E., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013967 · Cited by 45
The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHD: Does Composition Matter?
Hodgkins, P., Shaw, M., McCarthy, S., & Sallee, F. R. (2012) · CNS Drugs · doi:10.2165/11599630-000000000-00000 · Cited by 57
Cortese, S., Panei, P., Arcieri, R., Germinario, E. A. P., Capuano, A., Margari, L., Chiarotti, F., & Curatolo, P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0266-7 · Cited by 51
Pediatric Psychopharmacology for Treatment of ADHD, Depression, and Anxiety
Southammakosane, C., & Schmitz, K. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1581 · Cited by 58
Mokona, H., Belete, H., Worku, A. G., Zerihun, A., Yimer, S., & Leta, K. (2019) · Behavioural Neurology · doi:10.1155/2019/1753580 · Cited by 59
Attention Deficit Hyperactivity Disorder and Athletes
White, R. D., Harris, G. D., & Gibson, M. E. (2013) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738113484679 · Cited by 52
Cognitive Behavioral Therapy for Adolescents with ADHD
Antshel, K. M., & Olszewski, A. K. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.001 · Cited by 44
Faraone, S. V., McBurnett, K., Sallee, F. R., Steeber, J., & López, F. A. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.09.005 · Cited by 44
Bruxel, E. M., Salatino‐Oliveira, A., Genro, J. P., Zeni, C., Polanczyk, G. V., Chazan, R., Rohde, L. A., & Hutz, M. H. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.25 · Cited by 53
Graziano, P. A., Bagner, D. M., Waxmonsky, J. G., Reid, A. M., McNamara, J. P. H., & Geffken, G. R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.245 · Cited by 52
Voiding postponement in children—a systematic review
von Gontard, A., Niemczyk, J., Wagner, C., & Equit, M. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0814-1 · Cited by 47
Pliszka, S. R., Wilens, T. E., Bostrom, S., Arnold, V. K., Marraffino, A., Cutler, A. J., López, F. A., DeSousa, N. J., Sallee, F. R., Incledon, B., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0084 · Cited by 44
“Long-acting psychostimulants, including methylphenidate (MPH), are recommended as first-line pharmacotherapy for youth with ADHD (Pliszka et al. 2007; Wolraich et al. 2011).”
Self-citationAttention-deficit/hyperactivity disorder medication and seizures
Wiggs, K. K., Chang, Z., Quinn, P. D., Hur, K., Gibbons, R., Dunn, D., Brikell, I., Larsson, H., & D'Onofrio, B. M. (2018) · Neurology · doi:10.1212/wnl.0000000000005213 · Cited by 44
Rosch, K. S., Fosco, W. D., Pelham, W. E., Waxmonsky, J. G., Bubnik, M. G., & Hawk, L. W. (2016) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-015-0031-x · Cited by 43
“2005), and about 70–80 % show a positive clinical response to MPH (Pliszka 2007).”
InfluentialHammerness, P., Biederman, J., Petty, C., Henin, A., & Moore, C. M. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00226.x · Cited by 53
Chacko, A., Merrill, B. M., Kofler, M. J., & Fabiano, G. A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02890-3 · Cited by 72
Hammerness, P., Georgiopoulos, A., Doyle, R. L., Utzinger, L., Schillinger, M., Martelon, M., Brodziak, K., Biederman, J., & Wilens, T. E. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0126 · Cited by 43
López, F. A., & Leroux, J. R. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-013-0106-x · Cited by 43
Adult ADHD Symptoms and Satisfaction With Life: Does Age and Sex Matter?
Oerbeck, B., Øvergaard, K. R., Pripp, A. H., Aase, H., Reichborn‐Kjennerud, T., & Zeiner, P. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715612257 · Cited by 49
Childress, A. C., Kollins, S. H., Cutler, A. J., Marraffino, A., & Sikes, C. R. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0002 · Cited by 45
Attention Deficit Hyperactivity Disorder in Preschool-Age Children
Tandon, M., & Pergjika, A. (2017) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2017.02.007 · Cited by 56
Markowitz, J. S., & Patrick, K. S. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0071 · Cited by 48
Mezzanotte, C. (2020) · OECD education working papers · doi:10.1787/49af95e0-en · Cited by 63
Motor timing deficits in children with Attention-Deficit/Hyperactivity disorder
Zelaznik, H. N., Vaughn, A. J., Green, J. T., Smith, A. L., Hoza, B., & Linnea, K. S. (2011) · Human Movement Science · doi:10.1016/j.humov.2011.05.003 · Cited by 54
Hodgkins, P., Sasané, R., Christensen, L., Harley, C., & Liu, F. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.623158 · Cited by 45
Fabiano, G. A., Schatz, N. K., Aloe, A. M., Pelham, W. E., Smyth, A. C., Zhao, X., Merrill, B. M., Macphee, F. L., Ramos, M. C., Hong, N., et al. (2021) · Review of Educational Research · doi:10.3102/00346543211025092 · Cited by 57
Childhood attention-deficit/hyperactivity disorder
Verkuijl, N., Perkins, M., & Fazel, M. (2015) · BMJ · doi:10.1136/bmj.h2168 · Cited by 42
Ermer, J. C., Adeyi, B. A., & Pucci, M. L. (2010) · CNS Drugs · doi:10.2165/11539410-000000000-00000 · Cited by 45
Carlson, G. A., Potegal, M., Margulies, D., Basile, J., & Gutkovich, Z. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00793.x · Cited by 42
Attention deficit hyperactivity disorder
Antshel, K. M., & Barkley, R. A. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64148-9.00003-x · Cited by 57
Lawson, K. A., Johnsrud, M. T., Hodgkins, P., Sasané, R., & Crismon, M. L. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.021 · Cited by 43
Review of Attention-Deficit/Hyperactivity Disorder Comorbid with Oppositional Defiant Disorder
Hazell, P. (2010) · Australasian Psychiatry · doi:10.3109/10398562.2010.498049 · Cited by 49
Najib, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.01.015 · Cited by 40
Doffer, D. P. A., Dekkers, T. J., Hornstra, R., der Oord, S. V., Luman, M., Leijten, P. H. O., Hoekstra, P. J., van den Hoofdakker, B. J., & Groenman, A. P. (2023) · JCPP Advances · doi:10.1002/jcv2.12196 · Cited by 62
Findling, R. L., Cutler, A. J., Saylor, K., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Childress, A. C. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0088 · Cited by 40
Rowles, B. M., & Findling, R. L. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.120 · Cited by 41
Katzman, M. A., & Sternat, T. (2014) · CNS Drugs · doi:10.1007/s40263-014-0175-1 · Cited by 48
Traumatic Brain Injury, Sleep Disorders, and Psychiatric Disorders: An Underrecognized Relationship
Morse, A. M., & Garner, D. (2018) · Medical Sciences · doi:10.3390/medsci6010015 · Cited by 56
Nagashima, M., Monden, Y., Dan, I., Dan, H., Tsuzuki, D., Mizutani, T., Kyutoku, Y., Gunji, Y., Momoi, M. Y., Watanabe, E., et al. (2014) · Neurophotonics · doi:10.1117/1.nph.1.1.015001 · Cited by 43
Setyawan, J., Fridman, M., Grebla, R. C., Harpin, V., Korst, L. M., & Quintero, J. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715597410 · Cited by 45
Frölich, J., Banaschewski, T., Döpfner, M., & Görtz‐Dorten, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.922542 · Cited by 41
Park, C., Rouzi, M. D., Atique, M. M. U., Finco, M. G., Mishra, R. K., Barba-Villalobos, G., Crossman, E., Amushie, C., Nguyen, J., Calarge, C. A., et al. (2023) · Sensors · doi:10.3390/s23104949 · Cited by 47
Attention-Deficit Hyperactivity Disorder and the Athlete: New Advances and Understanding
Parr, J. W. (2011) · Clinics in Sports Medicine · doi:10.1016/j.csm.2011.03.007 · Cited by 45
Stimulant Dosing for Children With ADHD: A Medical Claims Analysis
Olfson, M., Marcus, S., & Wan, G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31818b1c8f · Cited by 39
Waxmonsky, J. G., Waschbusch, D. A., Pelham, W. E., Draganac-Cardona, L., Rotella, B., & Ryan, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05496pur · Cited by 39
Simpson, H. A., Jung, L., & Murphy, T. K. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0223-1 · Cited by 44
Rezaei, M., Kamarzard, T. S., & Razavi, M. N. (2018) · Annals of Applied Sport Science · doi:10.29252/aassjournal.6.4.17 · Cited by 46
Wong, I. C. K., Banaschewski, T., Buitelaar, J., Cortese, S., Döpfner, M., Simonoff, E., & Coghill, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30096-3 · Cited by 39
Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends
Girand, H. L., Litkowiec, S., & Sohn, M. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2832 · Cited by 41
Sallee, F. R. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0160 · Cited by 39
Baweja, R., Belin, P. J., Humphrey, H. H., Babocsai, L., Pariseau, M. E., Waschbusch, D. A., Hoffman, M. T., Akinnusi, O. O., Haak, J. L., Pelham, W. E., et al. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0053 · Cited by 40
Gruenwald, J., & Schlarb, A. A. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s118076 · Cited by 53
Denchev, P., Kaltman, J. R., Schoenbaum, M., & Vitiello, B. (2010) · Circulation · doi:10.1161/circulationaha.109.901256 · Cited by 38
Metadata
- Authors
- Pliszka, S.
- Affiliations
- American Academy of Child and Adolescent Psychiatry (US)
- Corresponding author
- Pliszka, Steven
- ORCID
- Pliszka, Steven
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 46
- Issue
- 7
- Pages
- 894-921
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2114290463
- Cited by
- 1,765
- References
- 181
- Citations by year
- 2026: 39 · 2025: 45 · 2024: 63 · 2023: 73 · 2022: 74 · 2021: 77 · 2020: 80 · 2019: 69 · 2018: 78 · 2017: 106 · 2016: 111 · 2015: 108 · 2014: 126 · 2013: 107 · 2012: 139
- FWCI
- 63.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, children, adolescents, clinical evaluation, comorbidities, etiology, psychopharmacological treatment, psychosocial interventions
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Humans, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.